论文部分内容阅读
目的:比较头孢硫脒与头孢他啶治疗小儿呼吸道感染的临床疗效。方法:96例呼吸道感染患儿依据给药种类不同,按随机数字表法分为头孢硫脒组(LM组)和头孢他啶组(TD组),每组48例。比较两组治疗总有效率、不良反应率、细菌清除率。结果:LM组的总有效率为91.7%,TD组的总有效率为93.7%,两组比较无统计学差异(P>0.05);LM组不良反应率为4.1%,TD不良反应率为8.3%,两组比较无统计学差异(P>0.05);LM组细菌清除率为88.4%;TD组细菌清除率为88.9%,差异无统计学意义(P>0.05)。结论:头孢硫脒与头孢他啶治疗小儿呼吸道感染均有很好的临床疗效,但头孢硫脒具有较少的不良反应,更适于临床应用。
Objective: To compare the clinical efficacy of cefathiamidine and ceftazidime in the treatment of pediatric respiratory infections. Methods: Ninety-six children with respiratory tract infection were divided into cefathiamidine group (LM group) and ceftazidime group (TD group) by random number table according to different administration types, 48 cases in each group. The total effective rate, adverse reaction rate and bacterial clearance rate of the two groups were compared. Results: The total effective rate was 91.7% in LM group and 93.7% in TD group, with no significant difference between the two groups (P> 0.05). The adverse reaction rate was 4.1% in LM group and 8.3% in TD group % Respectively. There was no significant difference between the two groups (P> 0.05). The bacterial clearance rate in LM group was 88.4%. The bacterial clearance rate in TD group was 88.9%, with no significant difference (P> 0.05). Conclusion: Both cefathiamidine and ceftazidime have a good clinical efficacy in the treatment of pediatric respiratory infections, but cefathiamidine has fewer adverse reactions and is more suitable for clinical application.